JP2000500437A - タキサンの半合成のための中間体およびそれらの製造方法 - Google Patents
タキサンの半合成のための中間体およびそれらの製造方法Info
- Publication number
- JP2000500437A JP2000500437A JP9516372A JP51637297A JP2000500437A JP 2000500437 A JP2000500437 A JP 2000500437A JP 9516372 A JP9516372 A JP 9516372A JP 51637297 A JP51637297 A JP 51637297A JP 2000500437 A JP2000500437 A JP 2000500437A
- Authority
- JP
- Japan
- Prior art keywords
- group
- general formula
- derivative
- iii
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 238000000034 method Methods 0.000 title claims abstract description 68
- 229940123237 Taxane Drugs 0.000 title claims abstract description 57
- 238000003786 synthesis reaction Methods 0.000 title claims abstract description 42
- 239000000543 intermediate Substances 0.000 title abstract description 14
- 238000002360 preparation method Methods 0.000 title abstract description 6
- DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 claims abstract description 40
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 26
- 150000004200 baccatin III derivatives Chemical class 0.000 claims abstract description 8
- 239000002253 acid Substances 0.000 claims description 56
- -1 hydrocarbon radical Chemical class 0.000 claims description 52
- 150000001875 compounds Chemical class 0.000 claims description 42
- 125000000217 alkyl group Chemical group 0.000 claims description 36
- 125000003118 aryl group Chemical group 0.000 claims description 27
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 25
- 150000002148 esters Chemical class 0.000 claims description 23
- 239000002243 precursor Substances 0.000 claims description 23
- 125000006239 protecting group Chemical group 0.000 claims description 23
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 22
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 22
- 239000000203 mixture Substances 0.000 claims description 22
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 18
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 17
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 17
- 229910052736 halogen Inorganic materials 0.000 claims description 16
- 150000002367 halogens Chemical group 0.000 claims description 16
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 16
- 150000002430 hydrocarbons Chemical group 0.000 claims description 15
- 125000001424 substituent group Chemical group 0.000 claims description 15
- 230000008569 process Effects 0.000 claims description 13
- 229910052799 carbon Inorganic materials 0.000 claims description 12
- 125000004122 cyclic group Chemical group 0.000 claims description 12
- 125000002252 acyl group Chemical group 0.000 claims description 11
- 238000007127 saponification reaction Methods 0.000 claims description 11
- IMSODMZESSGVBE-UHFFFAOYSA-N 2-Oxazoline Chemical compound C1CN=CO1 IMSODMZESSGVBE-UHFFFAOYSA-N 0.000 claims description 10
- 238000006434 Ritter amidation reaction Methods 0.000 claims description 10
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims description 9
- 230000002378 acidificating effect Effects 0.000 claims description 9
- 125000004993 haloalkoxycarbonyl group Chemical group 0.000 claims description 9
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 9
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 9
- 125000004665 trialkylsilyl group Chemical group 0.000 claims description 9
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 8
- 125000003545 alkoxy group Chemical group 0.000 claims description 8
- 125000003968 arylidene group Chemical group [H]C(c)=* 0.000 claims description 8
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 claims description 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 7
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 7
- 230000007062 hydrolysis Effects 0.000 claims description 7
- 238000006460 hydrolysis reaction Methods 0.000 claims description 7
- WADSJYLPJPTMLN-UHFFFAOYSA-N 3-(cycloundecen-1-yl)-1,2-diazacycloundec-2-ene Chemical compound C1CCCCCCCCC=C1C1=NNCCCCCCCC1 WADSJYLPJPTMLN-UHFFFAOYSA-N 0.000 claims description 6
- 150000001408 amides Chemical class 0.000 claims description 6
- 150000002825 nitriles Chemical class 0.000 claims description 6
- LJCZNYWLQZZIOS-UHFFFAOYSA-N 2,2,2-trichlorethoxycarbonyl chloride Chemical compound ClC(=O)OCC(Cl)(Cl)Cl LJCZNYWLQZZIOS-UHFFFAOYSA-N 0.000 claims description 5
- 239000000460 chlorine Substances 0.000 claims description 5
- 125000005843 halogen group Chemical group 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 125000001624 naphthyl group Chemical group 0.000 claims description 5
- 125000004797 2,2,2-trichloroethoxy group Chemical group ClC(CO*)(Cl)Cl 0.000 claims description 4
- 125000003504 2-oxazolinyl group Chemical group O1C(=NCC1)* 0.000 claims description 4
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 4
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 4
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 4
- 229910052794 bromium Inorganic materials 0.000 claims description 4
- 229910052801 chlorine Inorganic materials 0.000 claims description 4
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims description 4
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 4
- 125000005561 phenanthryl group Chemical group 0.000 claims description 4
- 125000003866 trichloromethyl group Chemical group ClC(Cl)(Cl)* 0.000 claims description 4
- 239000004215 Carbon black (E152) Substances 0.000 claims description 3
- 239000002841 Lewis acid Substances 0.000 claims description 3
- 229910021627 Tin(IV) chloride Inorganic materials 0.000 claims description 3
- 125000004653 anthracenylene group Chemical group 0.000 claims description 3
- VMPVEPPRYRXYNP-UHFFFAOYSA-I antimony(5+);pentachloride Chemical compound Cl[Sb](Cl)(Cl)(Cl)Cl VMPVEPPRYRXYNP-UHFFFAOYSA-I 0.000 claims description 3
- 229910052796 boron Inorganic materials 0.000 claims description 3
- 125000000524 functional group Chemical group 0.000 claims description 3
- 125000005179 haloacetyl group Chemical group 0.000 claims description 3
- 229930195733 hydrocarbon Natural products 0.000 claims description 3
- 150000007517 lewis acids Chemical class 0.000 claims description 3
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 claims description 3
- 150000007530 organic bases Chemical class 0.000 claims description 3
- 125000005562 phenanthrylene group Chemical group 0.000 claims description 3
- 125000001412 tetrahydropyranyl group Chemical group 0.000 claims description 3
- HPGGPRDJHPYFRM-UHFFFAOYSA-J tin(iv) chloride Chemical compound Cl[Sn](Cl)(Cl)Cl HPGGPRDJHPYFRM-UHFFFAOYSA-J 0.000 claims description 3
- XJDNKRIXUMDJCW-UHFFFAOYSA-J titanium tetrachloride Chemical group Cl[Ti](Cl)(Cl)Cl XJDNKRIXUMDJCW-UHFFFAOYSA-J 0.000 claims description 3
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims description 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 2
- 125000005428 anthryl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C3C(*)=C([H])C([H])=C([H])C3=C([H])C2=C1[H] 0.000 claims description 2
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000004957 naphthylene group Chemical group 0.000 claims description 2
- 150000003254 radicals Chemical class 0.000 claims 5
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 2
- KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 claims 2
- 150000005840 aryl radicals Chemical class 0.000 claims 1
- RQDXIWBZCFJVHX-UHFFFAOYSA-N boron;2,2,2-trifluoroacetic acid Chemical group [B].OC(=O)C(F)(F)F RQDXIWBZCFJVHX-UHFFFAOYSA-N 0.000 claims 1
- 125000001309 chloro group Chemical group Cl* 0.000 claims 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 claims 1
- 150000002170 ethers Chemical class 0.000 claims 1
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 claims 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 abstract description 17
- IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical compound O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 abstract description 3
- 238000007429 general method Methods 0.000 abstract description 3
- 150000002917 oxazolidines Chemical class 0.000 abstract description 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 96
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 90
- 239000000243 solution Substances 0.000 description 59
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 54
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 33
- 238000003756 stirring Methods 0.000 description 32
- 238000006243 chemical reaction Methods 0.000 description 29
- 238000005160 1H NMR spectroscopy Methods 0.000 description 28
- 239000012074 organic phase Substances 0.000 description 26
- 239000011541 reaction mixture Substances 0.000 description 25
- 239000003480 eluent Substances 0.000 description 22
- OVMSOCFBDVBLFW-VHLOTGQHSA-N 5beta,20-epoxy-1,7beta,13alpha-trihydroxy-9-oxotax-11-ene-2alpha,4alpha,10beta-triyl 4,10-diacetate 2-benzoate Chemical compound O([C@@H]1[C@@]2(C[C@H](O)C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)O)C(=O)C1=CC=CC=C1 OVMSOCFBDVBLFW-VHLOTGQHSA-N 0.000 description 20
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 20
- 239000000047 product Substances 0.000 description 20
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 18
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 18
- 229930012538 Paclitaxel Natural products 0.000 description 16
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 16
- 229960001592 paclitaxel Drugs 0.000 description 16
- 239000012043 crude product Substances 0.000 description 15
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 15
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 14
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- 238000012544 monitoring process Methods 0.000 description 12
- 238000010898 silica gel chromatography Methods 0.000 description 12
- YWLXLRUDGLRYDR-ZHPRIASZSA-N 5beta,20-epoxy-1,7beta,10beta,13alpha-tetrahydroxy-9-oxotax-11-ene-2alpha,4alpha-diyl 4-acetate 2-benzoate Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](O)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 YWLXLRUDGLRYDR-ZHPRIASZSA-N 0.000 description 11
- 235000008504 concentrate Nutrition 0.000 description 11
- 239000012141 concentrate Substances 0.000 description 11
- 239000008346 aqueous phase Substances 0.000 description 10
- 229930014667 baccatin III Natural products 0.000 description 10
- 229930190007 Baccatin Natural products 0.000 description 9
- 238000010511 deprotection reaction Methods 0.000 description 9
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 9
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 9
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 8
- 239000007864 aqueous solution Substances 0.000 description 8
- 229920006395 saturated elastomer Polymers 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- 239000006188 syrup Substances 0.000 description 8
- 235000020357 syrup Nutrition 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- ZDZOTLJHXYCWBA-VCVYQWHSSA-N N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=4C=CC=CC=4)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 ZDZOTLJHXYCWBA-VCVYQWHSSA-N 0.000 description 7
- 239000013078 crystal Substances 0.000 description 7
- 229960003668 docetaxel Drugs 0.000 description 7
- 238000005886 esterification reaction Methods 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- BMYNFMYTOJXKLE-UHFFFAOYSA-N DL-isoserine Natural products NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 6
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Chemical compound N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 6
- 150000001576 beta-amino acids Chemical group 0.000 description 6
- 238000004587 chromatography analysis Methods 0.000 description 6
- 238000007142 ring opening reaction Methods 0.000 description 6
- 239000000741 silica gel Substances 0.000 description 6
- 229910002027 silica gel Inorganic materials 0.000 description 6
- RZARFIRJROUVLM-GVHYBUMESA-N (3r)-3-amino-2-hydroxy-3-phenylpropanoic acid Chemical compound OC(=O)C(O)[C@H](N)C1=CC=CC=C1 RZARFIRJROUVLM-GVHYBUMESA-N 0.000 description 5
- 230000032050 esterification Effects 0.000 description 5
- 235000019441 ethanol Nutrition 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 150000002918 oxazolines Chemical class 0.000 description 5
- TYLVGQKNNUHXIP-MHHARFCSSA-N 10-deacetyltaxol Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)C=4C=CC=CC=4)C=4C=CC=CC=4)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 TYLVGQKNNUHXIP-MHHARFCSSA-N 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 4
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 4
- DCFKHNIGBAHNSS-UHFFFAOYSA-N chloro(triethyl)silane Chemical compound CC[Si](Cl)(CC)CC DCFKHNIGBAHNSS-UHFFFAOYSA-N 0.000 description 4
- 239000004020 conductor Substances 0.000 description 4
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 4
- 235000017557 sodium bicarbonate Nutrition 0.000 description 4
- BPBOFBFRBITMMR-UONOGXRCSA-N (4s,5r)-2,4-diphenyl-4,5-dihydro-1,3-oxazole-5-carboxylic acid Chemical compound C1([C@@H]2N=C(O[C@H]2C(=O)O)C=2C=CC=CC=2)=CC=CC=C1 BPBOFBFRBITMMR-UONOGXRCSA-N 0.000 description 3
- HOJZAHQWDXAPDJ-UHFFFAOYSA-N 3-anilino-2-hydroxypropanoic acid Chemical compound OC(=O)C(O)CNC1=CC=CC=C1 HOJZAHQWDXAPDJ-UHFFFAOYSA-N 0.000 description 3
- RGUKYNXWOWSRET-UHFFFAOYSA-N 4-pyrrolidin-1-ylpyridine Chemical compound C1CCCN1C1=CC=NC=C1 RGUKYNXWOWSRET-UHFFFAOYSA-N 0.000 description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 3
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 3
- 239000012346 acetyl chloride Substances 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- FOCAUTSVDIKZOP-UHFFFAOYSA-N chloroacetic acid Chemical compound OC(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-N 0.000 description 3
- 229940106681 chloroacetic acid Drugs 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 230000006698 induction Effects 0.000 description 3
- 238000007363 ring formation reaction Methods 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 2
- NOOLISFMXDJSKH-AEJSXWLSSA-N (+)-menthol Chemical compound CC(C)[C@H]1CC[C@H](C)C[C@@H]1O NOOLISFMXDJSKH-AEJSXWLSSA-N 0.000 description 2
- WEIGDWIZZXHFRS-JGVFFNPUSA-N (4s,5r)-2-oxo-4-phenyl-1,3-oxazolidine-5-carboxylic acid Chemical compound OC(=O)[C@@H]1OC(=O)N[C@H]1C1=CC=CC=C1 WEIGDWIZZXHFRS-JGVFFNPUSA-N 0.000 description 2
- 229930182986 10-Deacetyltaxol Natural products 0.000 description 2
- PKUPAJQAJXVUEK-UHFFFAOYSA-N 2-phenoxyacetyl chloride Chemical compound ClC(=O)COC1=CC=CC=C1 PKUPAJQAJXVUEK-UHFFFAOYSA-N 0.000 description 2
- XVMSFILGAMDHEY-UHFFFAOYSA-N 6-(4-aminophenyl)sulfonylpyridin-3-amine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=N1 XVMSFILGAMDHEY-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- QQONPFPTGQHPMA-UHFFFAOYSA-N Propene Chemical group CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- 241001116498 Taxus baccata Species 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 2
- LVZGQWKTUCVPBQ-UHFFFAOYSA-N acetic acid;trifluoroborane Chemical compound CC(O)=O.FB(F)F LVZGQWKTUCVPBQ-UHFFFAOYSA-N 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 239000002246 antineoplastic agent Substances 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 238000013480 data collection Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000002050 diffraction method Methods 0.000 description 2
- 238000001640 fractional crystallisation Methods 0.000 description 2
- 125000004438 haloalkoxy group Chemical group 0.000 description 2
- 125000001188 haloalkyl group Chemical group 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 229940041616 menthol Drugs 0.000 description 2
- XONPDZSGENTBNJ-UHFFFAOYSA-N molecular hydrogen;sodium Chemical compound [Na].[H][H] XONPDZSGENTBNJ-UHFFFAOYSA-N 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 125000004304 oxazol-5-yl group Chemical group O1C=NC=C1* 0.000 description 2
- 230000020477 pH reduction Effects 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 238000010956 selective crystallization Methods 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 230000000707 stereoselective effect Effects 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000010189 synthetic method Methods 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 150000003952 β-lactams Chemical class 0.000 description 2
- 229940075966 (+)- menthol Drugs 0.000 description 1
- PZAQBHDGXLMLRH-VQTJNVASSA-N (2R,3S)-3-[benzoyloxy(triethylsilyl)amino]-2-hydroxy-3-phenylpropanoic acid Chemical compound C(C1=CC=CC=C1)(=O)ON([C@H]([C@@H](O)C(=O)O)C1=CC=CC=C1)[Si](CC)(CC)CC PZAQBHDGXLMLRH-VQTJNVASSA-N 0.000 description 1
- HYJVYOWKYPNSTK-UONOGXRCSA-N (2r,3s)-3-benzamido-2-hydroxy-3-phenylpropanoic acid Chemical compound N([C@H]([C@@H](O)C(O)=O)C=1C=CC=CC=1)C(=O)C1=CC=CC=C1 HYJVYOWKYPNSTK-UONOGXRCSA-N 0.000 description 1
- DYLIWHYUXAJDOJ-OWOJBTEDSA-N (e)-4-(6-aminopurin-9-yl)but-2-en-1-ol Chemical compound NC1=NC=NC2=C1N=CN2C\C=C\CO DYLIWHYUXAJDOJ-OWOJBTEDSA-N 0.000 description 1
- ZQXCQTAELHSNAT-UHFFFAOYSA-N 1-chloro-3-nitro-5-(trifluoromethyl)benzene Chemical compound [O-][N+](=O)C1=CC(Cl)=CC(C(F)(F)F)=C1 ZQXCQTAELHSNAT-UHFFFAOYSA-N 0.000 description 1
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 1
- HALONVPKHYIEQU-UHFFFAOYSA-N 3-phenyloxirane-2-carboxylic acid Chemical compound OC(=O)C1OC1C1=CC=CC=C1 HALONVPKHYIEQU-UHFFFAOYSA-N 0.000 description 1
- FBXGQDUVJBKEAJ-UHFFFAOYSA-N 4h-oxazin-3-one Chemical compound O=C1CC=CON1 FBXGQDUVJBKEAJ-UHFFFAOYSA-N 0.000 description 1
- YWLXLRUDGLRYDR-LUPIKGFISA-N 7-epi-10-deacetylbaccatin iii Chemical group O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](O)C[C@]1(O)C3(C)C)=O)(C)[C@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 YWLXLRUDGLRYDR-LUPIKGFISA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 101100438156 Arabidopsis thaliana CAD7 gene Proteins 0.000 description 1
- 229910015900 BF3 Inorganic materials 0.000 description 1
- NHMSEMKTDAYSGW-QOZDAIMOSA-N Baccatin I Natural products O=C(O[C@H]1[C@H](OC(=O)C)C=2C(C)(C)[C@H]([C@@H](OC(=O)C)[C@@H]3[C@]1(C)[C@H](OC(=O)C)C[C@@H](OC(=O)C)[C@]13OC1)C[C@@H](OC(=O)C)C=2C)C NHMSEMKTDAYSGW-QOZDAIMOSA-N 0.000 description 1
- 240000008564 Boehmeria nivea Species 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- 101150071647 CAD4 gene Proteins 0.000 description 1
- 101100322652 Catharanthus roseus ADH13 gene Proteins 0.000 description 1
- 101100087088 Catharanthus roseus Redox1 gene Proteins 0.000 description 1
- DBXFAPJCZABTDR-KUEXGRMWSA-N Cephalomannine Natural products O=C(O[C@@H]1C(C)=C2[C@@H](OC(=O)C)C(=O)[C@]3(C)[C@@H](O)C[C@@H]4[C@](OC(=O)C)([C@H]3[C@H](OC(=O)c3ccccc3)[C@@](O)(C2(C)C)C1)CO4)[C@@H](O)[C@H](NC(=O)/C(=C\C)/C)c1ccccc1 DBXFAPJCZABTDR-KUEXGRMWSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 244000292411 Excoecaria agallocha Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- WYNCHZVNFNFDNH-UHFFFAOYSA-N Oxazolidine Chemical compound C1COCN1 WYNCHZVNFNFDNH-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 241001575049 Sonia Species 0.000 description 1
- 241001116495 Taxaceae Species 0.000 description 1
- 241001116500 Taxus Species 0.000 description 1
- 241000202349 Taxus brevifolia Species 0.000 description 1
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 239000003377 acid catalyst Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 150000001266 acyl halides Chemical class 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 238000011914 asymmetric synthesis Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- 125000003460 beta-lactamyl group Chemical group 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 125000000319 biphenyl-4-yl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004744 butyloxycarbonyl group Chemical group 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- DBXFAPJCZABTDR-WBYYIXQISA-N cephalomannine Chemical compound O([C@@H]1[C@]2(O)C[C@@H](C(=C([C@@H](OC(C)=O)C(=O)[C@]3(C)[C@@H](O)C[C@H]4OC[C@]4([C@H]31)OC(C)=O)C2(C)C)C)OC(=O)[C@H](O)[C@@H](NC(=O)C(/C)=C/C)C=1C=CC=CC=1)C(=O)C1=CC=CC=C1 DBXFAPJCZABTDR-WBYYIXQISA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000010568 chiral column chromatography Methods 0.000 description 1
- CZKMPDNXOGQMFW-UHFFFAOYSA-N chloro(triethyl)germane Chemical compound CC[Ge](Cl)(CC)CC CZKMPDNXOGQMFW-UHFFFAOYSA-N 0.000 description 1
- 125000004965 chloroalkyl group Chemical group 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000006345 epimerization reaction Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000005227 gel permeation chromatography Methods 0.000 description 1
- 229910002804 graphite Inorganic materials 0.000 description 1
- 239000010439 graphite Substances 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 125000001072 heteroaryl group Chemical group 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000012456 homogeneous solution Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 238000006317 isomerization reaction Methods 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- HAFFKTJSQPQAPC-UHFFFAOYSA-N methyl 3-phenyloxirane-2-carboxylate Chemical compound COC(=O)C1OC1C1=CC=CC=C1 HAFFKTJSQPQAPC-UHFFFAOYSA-N 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical group C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 239000012038 nucleophile Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 125000003566 oxetanyl group Chemical group 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- JWHOQZUREKYPBY-UHFFFAOYSA-N rubonic acid Natural products CC1(C)CCC2(CCC3(C)C(=CCC4C5(C)CCC(=O)C(C)(C)C5CC(=O)C34C)C2C1)C(=O)O JWHOQZUREKYPBY-UHFFFAOYSA-N 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 150000003354 serine derivatives Chemical class 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- FZHAPNGMFPVSLP-UHFFFAOYSA-N silanamine Chemical compound [SiH3]N FZHAPNGMFPVSLP-UHFFFAOYSA-N 0.000 description 1
- 238000004467 single crystal X-ray diffraction Methods 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 239000012258 stirred mixture Substances 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- CMQCNTNASCDNGR-UHFFFAOYSA-N toluene;hydrate Chemical compound O.CC1=CC=CC=C1 CMQCNTNASCDNGR-UHFFFAOYSA-N 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- 229930195735 unsaturated hydrocarbon Natural products 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000004246 zinc acetate Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/81—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/82—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/87—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/26—Oxygen atoms attached in position 2 with hetero atoms or acyl radicals directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/48—Compounds containing oxirane rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0834—Compounds having one or more O-Si linkage
- C07F7/0838—Compounds with one or more Si-O-Si sequences
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
- C07F7/1872—Preparation; Treatments not provided for in C07F7/20
- C07F7/1892—Preparation; Treatments not provided for in C07F7/20 by reactions not provided for in C07F7/1876 - C07F7/1888
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epoxy Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines Containing Plant Substances (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1. 一般式I [式中、Arは、アリール基を表し、そして Rは、炭化水素基、好ましくは、1個以上のアルキル基によって場合によって は置換される直鎖または分枝アルキルもしくはシクロアルキルを表す] のシス−β−アリールグリシド酸エステル誘導体が、Ritter反応による単 一段階において転化されて、レジオ−および立体特異的に、β−N−アルキルア ミドおよびα−ヒドロキシル、またはそれらの環状前駆物質を導入される、タキ サン側鎖前駆物質の製造方法であって: a 先に定義された一般式Iのシス−β−アリールグリシド酸エステル誘導体 と、式 R2−CN [式中、R2は、アリール基を表す] のニトリルとを、プロトン酸、および水の存在下で反応させることによって、一 般式IIa [式中、Ar,RおよびR2は先に定義されている] のβ−アリールイソセリン誘導体を得る、直鎖の直接合成;あるいは b 先に定義された一般式Iのシス−β−アリールグリシド酸エステ ル誘導体と、式 R’2−CN [式中、R2’は、先に定義されたR2か、または低級アルキルもしくは低級ペル ハロアルキル基、例えばトリクロロメチルを表す] のニトリルとを、ルイス酸、またはプロトン酸の存在下、無水媒質中で反応させ ることによって、一般式IIb [式中、Ar,RおよびR’2は先に定義されている] のオキサゾリンを得る、環状鎖の直接合成、 のいずれかよりなる方法。 2. Rが、高度に立体障害のあるキラル炭化水素基、有利には1個以上のア ルキル基によって置換されたシクロアルキル、特にシクロヘキシルの光学的に純 粋な鏡像異性体を表すことを特徴とする、請求の範囲1記載の方法。 3. Rが、メンチル基、特に(+)−メンチルの鏡像異性体の1つであるこ とを特徴とする、請求の範囲2記載の方法。 4. 一般式Iのシス−β−フェニルグリシド酸エステル誘導体が、(2R, 3R)立体配置をもち、そして得られる一般式IIaおよびIIbの誘導体が、 (2R,3S)立体配置をもつことを特徴とする、請求の範囲1〜3の1つに記 載の方法。 5. ArおよびR2がフェニルを表すことを特徴とする、請求の範囲1〜4 の1つに記載の方法。 6. 段階aにおけるプロトン酸が、硫酸、過塩素酸もしくはテトラフルオロ ホウ酸から選ばれ、段階bにおけるルイス酸が、ホウ素三フッ化酢酸錯体、ホウ 素三フッ化エーテル混和物、五塩化アンチモン、四塩化スズもしくは四塩化チタ ンから選ばれ、そして段階bにおけるプロトン酸がテトラフルオロホウ酸である ことを特徴とする、請求の範囲1〜5の1つに記載の方法。 7. 一般式IIaのβ−アリールイソセリン誘導体が、適当な保護基(GP )によるヒドロキシルの保護によって転化されて、一般式II’a[式中、Ar,RおよびR2は先に定義されており、そして GPは、タキサンの合成のために適当であるヒドロキシル官能基の保護基であっ て、特に、例えばメトキシメチル、1−エトキシエチル、ベンジルオキシメチル もしくは(β−トリメチルシリルエトキシ)メチル基のようなアルコキシエーテ ル、アラルコキシエーテル、アリールオキシエーテルまたはハロアルコキシカル ボニル基、テトラヒドロピラニルもしくはβ−アルコキシカルボニル基、β−ハ ロゲン化もしくはアルキルシリルエーテル、またはアルコキシアセチル、アリー ルオキシアセチル、ハロアセチルもしくはホルミル基から選ばれる保護基を表す ] の誘導体を得ることを特徴とする、請求の範囲1〜6の1つに記載の方法。 8. 一般式IIaのβ−アリールイソセリン誘導体が、請求の範囲 1〜5の1つに記載の一般式IIaのβ−アリールイソセリン誘導体を、ハロア ルコキシカルボニルエステル、特に2,2,2−トリクロロエトキシカルボニル (TrOC)と反応させ、そして次に、強い有機塩基、例えばジアザビシクロウ ンデセン(DBU)の存在下で環化させることによって、一般式IIIa [式中、ArおよびRは先に定義されている] の新規なオキサゾリジノン環状中間体に転化され、場合によっては、続いて、一 般式III’a[式中、ArおよびRは先に定義されており、そして R”2は、先に定義されたR’2、アルコキシ基、または少なくとも1個の不飽和 を含む直鎖または分枝アルキル基を表す] の対応するアミドに転化されることを特徴とする、請求の範囲1〜6の1つに記 載の方法。 9. 一般式IIbのオキサゾリンが、酸性媒質中で加水分解されて、一般式 IIIb [式中、Ar、RおよびR’2は先に定義されている] のβ−アリールイソセリン誘導体を生成し、場合によっては、続いて、一般式I II’b [式中、Ar、R、R’2およびR”2は先に定義されている] の対応するアミドに転化されることを特徴とする、請求の範囲1〜6の1つに記 載の方法。 10.一般式I [式中、Arは、先に定義されており、そして Rは、高度に立体障害のあるキラル炭化水素基の光学的に純粋な鏡像異性体を 表す] のシス−β−アリールグリシド酸エステル誘導体が、式 Ar−CHO のアルデヒドと、式 X−CH2−COOR [式中、ArおよびRは、先に定義されており、そして Xは、ハロゲン、特に塩素もしくは臭素を表す] のハロ酢酸エステルとを反応させることによって製造されることを特徴とする、 請求の範囲1〜9の1つに記載の方法。 11.Rが水素原子を表す先に定義された式IIa,II’a,II b,IIIa,III’a,IIIbおよびIII’bの誘導体が、制御下のけ ん化によって得られることを特徴とする、請求の範囲1〜10の1つに記載の方 法。 12.化合物が、次の一般式I,IIa,IIb,II’a,IIIbおよび III’b: [式中、Ar,R2,R’2,R”2およびGPは、請求の範囲1〜3および5の 1つにおいて定義されており、そして Rは、高度に立体障害のあるキラル炭化水素基の光学的に純粋な鏡像異性体を表 す] の誘導体から選ばれることを特徴とする、タキサン側鎖の前駆物質化合物。 13.Rが、メンチル基、特に(+)−メンチルの鏡像異性体の1つであるこ とを特徴とする、請求の範囲12記載の化合物。 14.一般式Iのシス−β−フェニルグリシド酸エステル誘導体が、(2R, 3R)立体配置をもち、そして一般式IIa,IIb,IIIbおよびIII’ bの誘導体が、(2R,3S)立体配置をもつことを 特徴とする、請求の範囲12および13のいずれかに記載の化合物。 15.化合物が、次の一般式IIIaおよびIII’a: [式中、Ar,RおよびR”2は、先に定義されているか、またはRは、水素原 子を表す] の誘導体から選ばれることを特徴とする、タキサン側鎖の前駆物質化合物。 16.化合物が、(2R,3S)立体配置をもつことを特徴とする、請求の範 囲15記載の化合物。 17.請求の範囲11記載の方法によって得られる、Rが水素原子を表す式I Ia,II’a,IIb,IIIa,III’a,IIIbおよびIII’bの 誘導体の1種を用いて、C−13ヒドロキシル官能基を担持している一般式Vの 適当なバッカチン(Baccatin)III誘導体をエステル化することによ る、一般式IV C−B IV のタキサンの製造方法。 式IV中、Bは、一般式V[式中、Acは、アセチル基を表し、 Bzは、ベンジル基を表し、 Meは、メチル基を表し、 R4は、アセチル基またはヒドロキシル官能基GP1の保護基を表し、そして R5は、ヒドロキシル官能基GP2の保護基を表す] の基を表し、そして Cは、次の式IIa,II’a,IIb,IIIa,III’a,IIIbお よびIII’b: [式中、Ar,R2,R’2,R”2およびGPは先に定義されている] の基から選ばれる側鎖を表す。 18.GP1およびGP2保護基が、互いに独立して、タキサンの半合成に使 用される慣用の基、例えばトリアルキルシリルもしくはTROC、または少なく とも1個のハロゲン原子を含む直鎖または分枝の大(bulky)ハロアルコキ シカルボニル基、カルボニル官能基に対するα炭素が少なくとも1個の酸素原子 を担持しているアシル基、またはトリアルキルゲルマニル基であるか、あるいは GP1およびGP2が一緒になって、式 −SiR7−O−SiR8− [式中、R7およびR8は、互いに独立して、立体障害のあるアルキル基を表す] の二価の基を形成することを特徴とする、請求の範囲17記載の方法。 19.カルボニル官能基に対するα炭素が少なくとも1個の酸素原子を担持し ているアシル基が、式 R6−O−CH2−CO− [式中、R6は、立体障害のあるアルキル基、シクロアルキル基もしくはアリー ル基を表す] のアルコキシ−もしくはアリールオキシアセチル基、または、式 [式中、Ar”は、アリーリデン基を表す] のアリーリデンジオキシアセチル基から選ばれることを特徴とする、請求の範囲 17および18のいずれかに記載の方法。 20.請求の範囲19記載の方法であって、 立体障害のあるアルキルが、ハロゲン、または、直鎖または分枝C1−C6アル キル、直鎖または分枝C1−C6アルコキシもしくはC3−C6シクロアルキル、ま たはアリール基から選ばれる1個以上の大(bulky)置換基によって置換さ れた直鎖または分枝C1−C6アルキル基であり、 シクロアルキルが、ハロゲン、または、直鎖または分枝C1−C6アルキル、直 鎖または分枝C1−C6アルコキシ、またはアリール基から選ばれる1個以上の大 置換基によって、場合によっては置換されるC3−C6シクロアルキル基、好まし くは、1個以上の直鎖または分枝C1−C6アルキル基によって置換されたシクロ ヘキシル基、例えばメンチル、そのラセミ体またはその鏡像異性体およびあらゆ る比率でのそれらの混合物であり、 アリールが、ハロゲン、または、直鎖または分枝C1−C6アルキル、直鎖また は分枝C1−C6アルコキシ、またはアリール基、特にフェニル基から選ばれる1 個以上の大置換基によって、場合によっては置換されるフェニル、ナフチル、ア ントリルもしくはフェナントリル基、好ましくは、エーテル結合に対してオルト −もしくはオルト’−において、 1または2個の上記大置換基によって場合によっては置換されるフェニル基であ り、 アリーリデンが、ハロゲン、または、直鎖または分枝C1−C6アルキル、直鎖 または分枝C1−C6アルコキシ、またはアリール基、特にフェニル基から選ばれ る1個以上の大置換基によって、場合によっては置換されるフェニレン、ナフチ レン、アントリレンもしくはフェナントリレン基である、 ことを特徴とする方法。 21.請求の範囲17および18のいずれかに記載の方法であって、R4がア セチル基を表し、そしてGP2が、トリアルキルシリル、2,2,2−トリクロ ロエトキシカルボニル、2,2,2−トリブロモエトキシカルボニル、2,2, 2,1−テトラクロロエトキシカルボニル、2,2,2−トリクロロ−t−ブト キシカルボニル、トリクロロメトキシカルボニル、フェノキシアセチルもしくは トリアルキルゲルマニル基を表すことを特徴とする方法。 22.請求の範囲17および18のいずれかに記載の方法であって、R4がG P1基を表し、そしてGP1およびGP2が、2,2,2−トリクロロエトキシ カルボニルもしくはフェノキシアセチル基を表すか、または一緒になって、式 −SiR7−O−SiR8− [式中、R7およびR8は、各々イソプロピル基を表す] の二価の基を形成することを特徴とする方法。 23.Cが、フェニルを表すArおよびR2をもつ式IIaの基を表し、そし てR4が、アセチル基を表すことを特徴とする、請求の範囲1 7〜21の1つに記載の方法。 24.続いて、一般式IVの誘導体が、加水分解により脱保護され、そして適 当であれば、一般式VI [式中、Ac,Bz,MeおよびR’2は、先の請求の範囲の1つに定義されて おり、 R4は、水素原子もしくはアセチル基を表し、そして R5は、水素原子を表す] のタキサン誘導体を生成するために、同時にまたは別に、式IIbもしくはII Iaの基のオキサゾリン環が開環されることを特徴とする、請求の範囲17〜2 3の1つに記載の方法。 25.一般式IVのタキサン誘導体。 C−B IV [式中、CおよびBは、Cが式IIa,II’a,IIb,IIIbもしくはI II’bの基を表す誘導体を除いては、請求の範囲17〜23の1つに定義され ており、そしてGP1および/またはGP2は、互いに独立して、タキサンの半 合成に使用される慣用の基、例えばトリアルキルシリルもしくはTrOCである ]。 26.バッカチンIII誘導体が、一般式V[式中、Acは、アセチル基を表し、 Bzは、ベンジル基を表し、 Meは、メチル基を表し、 R4は、アセチル基またはヒドロキシル官能基GP1の保護基を表し、 R5は、ヒドロキシル官能基GP2の保護基を表し、そして GP1およびGP2は、互いに独立して、TrOCを除く大ハロアルコキシカ ルボニル基、カルボニル官能基に対するα炭素が少なくとも1個の酸素原子を担 持しているアシル基、またはトリアルキルゲルマニル基であるか、あるいはGP 1およびGP2は一緒になって、式 −SiR7−O−SiR8−(式中、R7およびR8は、互いに独立して、立 体障害のあるアルキル基を表す)の二価の基を形成する] の誘導体から選ばれることを特徴とする、タキサンの半合成に使用されるバッカ チンIII誘導体。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR95/12739 | 1995-10-27 | ||
FR9512739A FR2740451B1 (fr) | 1995-10-27 | 1995-10-27 | Nouveaux intermediaires pour l'hemisynthese de taxanes, leurs procedes de preparation et leur utilisation dans la synthese generale des taxanes |
PCT/FR1996/001676 WO1997015562A1 (fr) | 1995-10-27 | 1996-10-25 | Intermediaires pour l'hemisynthese de taxanes et leurs procedes de preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2000500437A true JP2000500437A (ja) | 2000-01-18 |
Family
ID=9484016
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP9516372A Ceased JP2000500437A (ja) | 1995-10-27 | 1996-10-25 | タキサンの半合成のための中間体およびそれらの製造方法 |
Country Status (25)
Country | Link |
---|---|
US (5) | US6265587B1 (ja) |
EP (1) | EP0863887B1 (ja) |
JP (1) | JP2000500437A (ja) |
KR (1) | KR100489865B1 (ja) |
CN (1) | CN100374428C (ja) |
AT (1) | ATE212342T1 (ja) |
AU (1) | AU710314B2 (ja) |
BR (1) | BR9610908A (ja) |
CZ (1) | CZ125598A3 (ja) |
DE (1) | DE69618812T2 (ja) |
DK (1) | DK0863887T3 (ja) |
EE (1) | EE03610B1 (ja) |
ES (1) | ES2170876T3 (ja) |
FR (1) | FR2740451B1 (ja) |
GE (1) | GEP20001938B (ja) |
HU (1) | HU225507B1 (ja) |
IL (1) | IL155876A (ja) |
NO (1) | NO981823D0 (ja) |
NZ (1) | NZ320356A (ja) |
PL (1) | PL327458A1 (ja) |
PT (1) | PT863887E (ja) |
RU (1) | RU2159237C2 (ja) |
SK (1) | SK52398A3 (ja) |
TR (1) | TR199800713T2 (ja) |
WO (1) | WO1997015562A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009501134A (ja) * | 2005-06-10 | 2009-01-15 | フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド | ドセタキセルの製造法 |
WO2017006573A1 (ja) * | 2015-07-07 | 2017-01-12 | 忠勝 萬代 | パクリタキセル及びドセタキセルの側鎖前駆体の製造方法 |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2740451B1 (fr) * | 1995-10-27 | 1998-01-16 | Seripharm | Nouveaux intermediaires pour l'hemisynthese de taxanes, leurs procedes de preparation et leur utilisation dans la synthese generale des taxanes |
KR100225535B1 (ko) * | 1996-08-27 | 1999-10-15 | 정지석 | 파클리탁셀의 제조방법 |
US6150537A (en) * | 1997-12-12 | 2000-11-21 | Emory University | Methods for the esterification of alcohols and compounds useful therefor as potential anticancer agents |
KR100267596B1 (ko) * | 1998-04-17 | 2000-10-16 | 강재헌 | 베타-아미노-알파-하이드록시산과 균등한 옥사졸린 유도체의 입체선택적 합성방법 |
WO2001030770A1 (en) * | 1999-10-26 | 2001-05-03 | Dong Kook Pharmaceutical Co., Ltd. | Stereoselective synthesis of oxazoline derivative |
ES2178539B1 (es) * | 2000-03-14 | 2004-08-01 | Dong Kook Pharmaceutical Co., Ltd. | Procedimiento para la preparacion de un compuesto de oxazolina. |
WO2002066448A1 (en) * | 2001-02-20 | 2002-08-29 | Dabur India Limited | Method of preparation of paclitaxel (taxol) using 3-(alk-2-ynyloxy) carbonyl-5-oxazolidine carboxylic acid |
FR2846327B1 (fr) * | 2002-10-25 | 2006-03-24 | Merck Sante Sas | Derives de n-benzodioxolyl, n-benzodioxanyl et n-benzodioxepinyl arylcarboxamides utilisables dans le traitement de dyslipidemies et compositions pharmaceutiques les contenant. |
WO2006135655A2 (en) * | 2005-06-10 | 2006-12-21 | Florida State University Research Foundation, Inc. | Processes for the production of polycyclic fused ring compounds |
GB0701523D0 (en) * | 2007-01-26 | 2007-03-07 | Chatham Biotec Ltd | Semi-synthetic process for the preparation of taxane derivatives |
CN101468974B (zh) * | 2007-12-28 | 2011-02-09 | 上海百灵医药科技有限公司 | 多烯紫杉醇的半合成方法 |
PT2519332E (pt) | 2009-12-30 | 2014-05-26 | Basf Pharma Callanish Ltd | Processo de separação cromatográfica em leito móvel simulado para a purificação de ácidos gordos poli-insaturados |
GB201111595D0 (en) | 2011-07-06 | 2011-08-24 | Equateq Ltd | Improved process |
GB201111601D0 (en) | 2011-07-06 | 2011-08-24 | Equateq Ltd | New process |
GB201111591D0 (en) | 2011-07-06 | 2011-08-24 | Equateq Ltd | Further new process |
GB201111589D0 (en) | 2011-07-06 | 2011-08-24 | Equateq Ltd | New modified process |
GB201111594D0 (en) | 2011-07-06 | 2011-08-24 | Equateq Ltd | New improved process |
CN103508918B (zh) * | 2012-06-18 | 2015-09-09 | 上海医药工业研究院 | 带有环丁基的α-羟基β-氨基酯类化合物及其制备方法 |
GB201300354D0 (en) | 2013-01-09 | 2013-02-20 | Basf Pharma Callanish Ltd | Multi-step separation process |
US8802880B1 (en) | 2013-05-07 | 2014-08-12 | Group Novasep | Chromatographic process for the production of highly purified polyunsaturated fatty acids |
US9428711B2 (en) | 2013-05-07 | 2016-08-30 | Groupe Novasep | Chromatographic process for the production of highly purified polyunsaturated fatty acids |
EP2883860B1 (fr) | 2013-12-11 | 2016-08-24 | Novasep Process | Procédé chromatographique de production d'acides gras polyinsaturés |
JP6303017B2 (ja) | 2014-01-07 | 2018-03-28 | ノヴァセプ プロセスNovasep Process | 芳香族アミノ酸を精製する方法 |
CN112876503B (zh) * | 2021-03-18 | 2022-04-29 | 中国科学院兰州化学物理研究所 | 用于癌症硼中子俘获治疗药物的硼酸盐化合物及其制备 |
CN114195820B (zh) * | 2021-12-17 | 2023-11-10 | 中山大学 | 异丝氨酸衍生物及其制备与在紫杉醇合成中的应用 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4876399A (en) * | 1987-11-02 | 1989-10-24 | Research Corporation Technologies, Inc. | Taxols, their preparation and intermediates thereof |
US5008411A (en) * | 1988-05-24 | 1991-04-16 | Hoffmann-La Roche Inc. | Glycidic acid ester and process of preparation |
US5274300A (en) * | 1988-10-26 | 1993-12-28 | Sepracor, Inc. | Enzymatic hydrolysis of glycidate esters in the presence of bisulfite anion |
CA2023645C (fr) * | 1989-08-23 | 2002-03-26 | Jean-Noel Denis | Procede pour la preparation enantioselective de derives de la phenylisoserine |
US5304670A (en) | 1989-08-23 | 1994-04-19 | Centre National De La Recherche Scientifique | Process for the enantioselective preparation of phenylisoserine derivatives |
US5244803A (en) * | 1989-09-13 | 1993-09-14 | Tanabe Seiyaku Co., Ltd. | Process for preparing optically active 3-phenylglycidic acid esters |
FR2658513B1 (fr) * | 1990-02-21 | 1994-02-04 | Rhone Poulenc Sante | Procede de preparation de l'acide cis-beta-phenylglycidique-(2r,3r). |
FR2678930B1 (fr) * | 1991-07-10 | 1995-01-13 | Rhone Poulenc Rorer Sa | Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii. |
AU3140093A (en) * | 1991-11-22 | 1993-06-15 | University Of Mississippi, The | Synthesis and optical resolution of the taxol side chain and related compounds |
CA2119261C (en) * | 1992-12-23 | 2006-01-31 | Michael A. Poss | Novel sidechain-bearing taxanes and intermediates thereof |
FR2740451B1 (fr) * | 1995-10-27 | 1998-01-16 | Seripharm | Nouveaux intermediaires pour l'hemisynthese de taxanes, leurs procedes de preparation et leur utilisation dans la synthese generale des taxanes |
US6228955B1 (en) * | 1996-04-19 | 2001-05-08 | Chirotech Technology, Ltd. | Asymmetric epoxides, their synthesis and use |
-
1995
- 1995-10-27 FR FR9512739A patent/FR2740451B1/fr not_active Expired - Fee Related
-
1996
- 1996-10-25 CN CNB961978538A patent/CN100374428C/zh not_active Expired - Fee Related
- 1996-10-25 NZ NZ320356A patent/NZ320356A/xx unknown
- 1996-10-25 TR TR1998/00713T patent/TR199800713T2/xx unknown
- 1996-10-25 CZ CZ981255A patent/CZ125598A3/cs unknown
- 1996-10-25 JP JP9516372A patent/JP2000500437A/ja not_active Ceased
- 1996-10-25 US US09/065,041 patent/US6265587B1/en not_active Expired - Fee Related
- 1996-10-25 PL PL96327458A patent/PL327458A1/xx unknown
- 1996-10-25 EP EP96934977A patent/EP0863887B1/fr not_active Expired - Lifetime
- 1996-10-25 RU RU98110071/04A patent/RU2159237C2/ru not_active IP Right Cessation
- 1996-10-25 AT AT96934977T patent/ATE212342T1/de not_active IP Right Cessation
- 1996-10-25 HU HU9802487A patent/HU225507B1/hu not_active IP Right Cessation
- 1996-10-25 SK SK523-98A patent/SK52398A3/sk unknown
- 1996-10-25 DK DK96934977T patent/DK0863887T3/da active
- 1996-10-25 ES ES96934977T patent/ES2170876T3/es not_active Expired - Lifetime
- 1996-10-25 BR BR9610908A patent/BR9610908A/pt unknown
- 1996-10-25 AU AU73086/96A patent/AU710314B2/en not_active Ceased
- 1996-10-25 PT PT96934977T patent/PT863887E/pt unknown
- 1996-10-25 KR KR1019980703067A patent/KR100489865B1/ko not_active IP Right Cessation
- 1996-10-25 GE GEAP19964253A patent/GEP20001938B/en unknown
- 1996-10-25 WO PCT/FR1996/001676 patent/WO1997015562A1/fr active IP Right Grant
- 1996-10-25 EE EE9800149A patent/EE03610B1/xx not_active IP Right Cessation
- 1996-10-25 DE DE69618812T patent/DE69618812T2/de not_active Expired - Lifetime
-
1998
- 1998-04-23 NO NO981823A patent/NO981823D0/no not_active Application Discontinuation
-
2001
- 2001-04-18 US US09/836,326 patent/US6825365B2/en not_active Expired - Fee Related
-
2003
- 2003-05-12 IL IL155876A patent/IL155876A/en not_active IP Right Cessation
-
2004
- 2004-06-04 US US10/859,953 patent/US7279586B2/en not_active Expired - Fee Related
-
2005
- 2005-03-11 US US11/076,856 patent/US7220871B2/en not_active Expired - Fee Related
-
2007
- 2007-03-07 US US11/714,817 patent/US7432383B2/en not_active Expired - Fee Related
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009501134A (ja) * | 2005-06-10 | 2009-01-15 | フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド | ドセタキセルの製造法 |
WO2017006573A1 (ja) * | 2015-07-07 | 2017-01-12 | 忠勝 萬代 | パクリタキセル及びドセタキセルの側鎖前駆体の製造方法 |
JPWO2017006573A1 (ja) * | 2015-07-07 | 2017-08-17 | 忠勝 萬代 | パクリタキセル及びドセタキセルの側鎖前駆体の製造方法 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2000500437A (ja) | タキサンの半合成のための中間体およびそれらの製造方法 | |
JP2507830B2 (ja) | オキサジノンを使用するタキソ―ルの製造方法 | |
JP2500198B2 (ja) | 新規β−ラクタム | |
RU2098413C1 (ru) | Алкоголяты металлов | |
US5254703A (en) | Semi-synthesis of taxane derivatives using metal alkoxides and oxazinones | |
JP2004043439A (ja) | β−ラクタム | |
JPH0383956A (ja) | フエニルイソセリン誘導体のエナンチオ選択的製造方法 | |
US6020507A (en) | Synthesis of paclitaxel from baccatin III by protection of the 7-hydroxyl of baccatin III using a strong base and an electrophile | |
US7550608B2 (en) | Processes for the preparation of docetaxel | |
JP2003502290A (ja) | ジアルキルジクロロシランを用いるパクリタキセルの半合成 | |
US20100228038A1 (en) | Processes for the production of polycyclic fused ring compounds | |
RU2109010C1 (ru) | ПРОИЗВОДНОЕ β -ФЕНИЛИЗОСЕРИНА, СПОСОБ ЕГО СТЕРЕОСЕЛЕКТИВНОГО ПОЛУЧЕНИЯ, ИСХОДНОЕ СОЕДИНЕНИЕ ДЛЯ ЕГО ПОЛУЧЕНИЯ, СПОСОБ ПОЛУЧЕНИЯ ТАКСАНА И ПРОМЕЖУТОЧНЫЕ ПРОДУКТЫ | |
US6150537A (en) | Methods for the esterification of alcohols and compounds useful therefor as potential anticancer agents | |
CA2236293C (fr) | Intermediaires pour l'hemisynthese de taxanes et leurs procedes de preparation | |
IL150093A (en) | Baccatin derivatives, intermediary compounds for the hemisynthesis of taxanes and preparation processes therefor | |
MXPA98002923A (en) | Intermediary compounds for the detaxanism semisintesis and the preparation procedures of the mis | |
CA2576943A1 (fr) | Intermediaires pour l'hemisynthese de taxanes et leurs procedes de preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070807 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20071106 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20071217 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080206 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20080520 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20080818 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080917 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20081030 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20081120 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090106 |
|
A313 | Final decision of rejection without a dissenting response from the applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A313 Effective date: 20090518 |
|
A912 | Re-examination (zenchi) completed and case transferred to appeal board |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20090618 |